STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

AnaptysBio insider files Form 144 to sell 10,231 shares on NASDAQ

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AnaptysBio, Inc. (ANAB) Form 144 shows an intended sale of 10,231 common shares with an aggregate market value of $200,712.78 to be executed on or about 08/08/2025 through Morgan Stanley Smith Barney on NASDAQ. The filing states these shares were acquired by a stock option exercise on 08/08/2025 with payment in cash. The notice also discloses prior sales by the same person, HOLLINGS C RENTON: 20,925 shares sold 07/02/2025 for $493,189.70 and 3,015 shares sold 06/18/2025 for $72,269.55. The signer represents there is no undisclosed material adverse information.

Positive

  • Form 144 filed and details disclosed, including broker, sale date, and aggregate market value, demonstrating regulatory compliance.
  • Securities were acquired via stock option exercise with cash payment as explicitly stated in the filing.

Negative

  • Insider selling reported: HOLLINGS C RENTON sold 20,925 shares on 07/02/2025 for $493,189.70 and 3,015 shares on 06/18/2025 for $72,269.55.
  • Planned sale of 10,231 shares valued at $200,712.78 is scheduled for 08/08/2025, indicating continued insider monetization.

Insights

TL;DR Insider exercised options and plans a modest sale; filing details are disclosed and likely immaterial to capitalization.

The filing documents a stock option exercise that created 10,231 shares, immediately slated for sale via Morgan Stanley Smith Barney on NASDAQ for $200,712.78. Given the reported shares outstanding of 27,996,963, the planned sale represents a very small fraction of total capitalization (approximately 0.037%). The filing also lists two recent sales by the same person on 07/02/2025 and 06/18/2025, showing prior monetization activity. For investors, the item is transparent but not likely market-moving based on size alone.

TL;DR Proper Form 144 disclosure and a signed representation reduce regulatory risk; multiple sales by the same individual warrant attention.

The notice includes required disclosures: acquisition method (stock option exercise), payment method (cash), broker (Morgan Stanley Smith Barney) and an affirmation that no material nonpublic information is known. The form also records recent sales by HOLLINGS C RENTON on 07/02/2025 and 06/18/2025. From a compliance standpoint, the filing appears complete; governance review would note repeated insider sales but the absolute sizes disclosed are modest relative to total shares outstanding.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ANAB Form 144 disclose?

The filing discloses a planned sale of 10,231 common shares valued at $200,712.78 to be sold on or about 08/08/2025 via Morgan Stanley Smith Barney on NASDAQ.

Who is the seller named in the filing for ANAB?

The filing identifies HOLLINGS C RENTON as the person associated with the disclosed sales.

How were the 10,231 ANAB shares acquired?

The shares were acquired by a stock option exercise on 08/08/2025 and payment was made in cash, as stated in the form.

Were there prior sales by the same person in the past three months?

Yes. The form lists sales of 20,925 shares on 07/02/2025 for $493,189.70 and 3,015 shares on 06/18/2025 for $72,269.55.

On which exchange will the ANAB shares be sold?

The planned sale is listed to occur on NASDAQ through Morgan Stanley Smith Barney.
Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.23B
26.07M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO